Assuring the Safe and Appropriate Management of Anemia in Two Patient Populations: Cancer and Chronic Kidney Disease Program Overview

Program Overview

Please read the following program information before accessing the presentations using links located at the bottom of this page

Release Date:  March 1, 2009              Expiration Date:  February 28, 2010

Accreditation for Pharmacists

ACPE LogoThe American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program provides 2.0 hours (0.2 CEUs) of continuing education credit (program number 204-000-08-467-H01P).

Methods and Format

This is an online activity consisting of audio and slides for three presentations, a post-test, and an activity evaluation tool. Participants must view all presentations, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 2 hours. This activity is provided free of charge.

Target Audience

This continuing education program is beneficial for all pharmacists, including clinicians, managers, and educators who are interested in learning about current trends in the management of anemia in patients with chronic kidney disease and in patients with chemotherapy induced anemia.

Activity Content

Click here to view an overview of the activity content.

Learning Objectives

At the conclusion of this knowledge-based educational activity, participants should be able to

Faculty

Howard I. Cohen, M.S., R.Ph., FASHP
Program Chair
Corporate Director of Pharmacy Services
Universal Health Services, Inc.
King of Prussia, Pennsylvania

Darren W. Grabe, Pharm.D.
Associate Professor of Pharmacy Practice
Albany Nephrology Pharmacy Group
Albany College of Pharmacy
Albany, New York

Marlo A. Blazer, Pharm.D.
Oncology Pharmacist
The Arthur G. James Cancer Hospital and
Richard J. Solove Research Institute
The Ohio State University Medical Center
Columbus, Ohio

Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s and the Accreditation Council for Pharmacy Education's Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of program content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.

The faculty and planners report the following relationships:

Howard I. Cohen, M.S., R.Ph., FASHP, reports no relationships pertinent to this activity.

Darren W. Grabe, Pharm.D., reports no relationships pertinent to this activity.

Marlo A. Blazer, Pharm.D., reports that she has consulted previously for Amgen.

Ron DeChant, M.S., R.Ph., reports no relationships pertinent to this activity.

This activity is supported by an educational grant from Centocor Ortho Biotech.

Launch Presentation

Launch PresentationManaging Anemia in Patients with Cancer and Chronic Kidney Disease: Common Goal of Assuring Safe and Appropriate Therapy (35 minutes)
Howard I. Cohen, M.S., R.Ph., FASHP

Launch PresentationManaging Anemia: Case Studies in Patients with Chemotherapy-Induced Anemia (33 minutes)
Marlo A. Blazer, Pharm.D.

Launch PresentationManaging Anemia: Case Studies in Patients with Chronic Kidney Disease (37 minutes)
Darren W. Grabe, Pharm.D.

*Allow additional time to complete the post-test and evaluation.

Download Post-Test

Click here to print the post-test for your reference.  Please note that to be eligible for continuing education credit, you must go to the ASHP Learning Center and complete the test online.